Passage BIO, Inc. — Director's Dealing 2025

May 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2025-05-28

Reporting Person: Kapadia Sandip (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-28	Director Stock Option (right to buy)	$0.3598	A	201857	Acquired	2035-05-28	Common Stock (201857)	Direct

Footnotes

F1: The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.